Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. - Wikidata - wikimedia - TriplyDB

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.

http://www.wikidata.org/entity/Q34405742

about

Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics Use Your Words Carefully: What Is a Chronic Disease?Recent Insights into the HIV/AIDS Pandemic.Osteoporosis in postmenopausal women living with HIV Barriers to HIV Cure.Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.Impairments of Motor Function While Multitasking in HIV.Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care Tryptophan catabolism and immune activation in primary and chronic HIV infection The effect of adherence to guidelines for initial antiretroviral therapy on 1-year outcomes: a French cohort study Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.Cost and safety of assisted reproductive technologies for human immunodeficiency virus-1 discordant couples.Risk factors for early mortality after AIDS in the cART era: A population-based cohort study in Italy People with diagnosed HIV infection not attending for specialist clinical care: UK national review.Four-Stage Audit Demonstrating Increased Uptake of HIV Testing in Acute Neurology Admissions Using Staged Practical Interventions A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project.Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin.Dentistry and HIV/AIDS related stigma.The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.Joint analysis of longitudinal and survival AIDS data with a spatial fraction of long-term survivors: A Bayesian approach.Human immunodeficiency virus and liver disease: An update.The Role of Early HIV Status Disclosure in Retention in HIV Care Running Backwards: Consequences of Current HIV Incidence Rates for the Next Generation of Black MSM in the United States.Use and Predictors of End-of-Life Care Among HIV Patients in a Safety Net Health System.Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study.Systemic Cytokine Levels Do Not Predict CD4(+) T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies.Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain The menopause transition in women living with HIV: current evidence and future avenues of research Does systemic inflammation and immune activation contribute to fracture risk in HIV?Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland.Is HIV Painful? An Epidemiologic Study of the Prevalence and Risk Factors for Pain in HIV-infected Patients.Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study.Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection.

P2860

Q28073408-954BFF6F-A87D-459F-B8ED-D346BD51EFA9 Q28551803-205AE654-F63C-4AF0-B681-C670021A3312 Q28553516-F73BB5BF-5EED-4D85-A0E0-8CC0361CA99F Q28555090-4CEAF4F1-BCF4-4416-8C34-720DA110DA7E Q28595560-57B7E786-1B0D-408E-88A6-31AE30CE36DC Q30235024-8022BFCF-E09C-4B34-ABFE-16D5FA963C9C Q30240606-1FFB1156-54C0-4339-8166-4FFB4BAF6B3D Q30245414-A47AB438-930A-48FA-A8ED-6F69171798AF Q30252460-628B0DF5-1F5D-4329-8D94-D6B8099D84A0 Q33611467-0CA9E267-332A-4494-85BF-B7A2F8C3165F Q33668524-E7363367-C345-41C8-BE49-495CB192F01D Q33697163-907ED750-B118-450B-ADC5-C871371BE295 Q34517842-31C09041-0122-4EBC-A6CC-CB7239C76B0F Q35124919-C66031AA-EC0C-4DA6-A2E2-A86FF51B91E4 Q35567815-46DAD3AA-4219-4F2A-9025-43139F08A12B Q35661739-BD56E25A-1A9C-40F6-B885-EBB6D7C50568 Q35738366-B84A8B9A-C439-45E0-B3C3-B329443166A5 Q35763402-CEE98881-7041-4B01-8D51-373C8E9579BE Q36144465-8CAEA3F1-CFEF-4B14-ACF0-729F3032A2C6 Q36153952-7746D290-E276-47CE-8FD5-8A12C98D930B Q36171153-533374F9-3F8E-4475-96C6-62C1210E8AC9 Q36197957-276157EF-43E3-4486-A85A-A432B6B3B90E Q36290647-5C5E1715-9DDD-48AD-A8A9-B5A6A317A0CF Q36360961-C2C4AA48-14E5-4ED6-BE22-EB8A0E283EF2 Q36378109-0FCACE7A-7255-4388-945D-03F2292F5277 Q36385895-3D4880CE-B953-41D0-A2BF-90AD01A6EEC7 Q36479966-A412C150-F286-4F64-B8E5-C8C28F64329C Q36608028-A125D4D8-3B96-4544-B665-DD14E30EB02E Q36650552-8C730FCC-AA35-4572-8B02-097A13DF9104 Q36661588-00ADEC78-7EC9-4713-9356-CBE60531B899 Q36783202-C2F0274A-4899-4430-BE58-7FE79959AABA Q37046208-ECCCC797-F9D7-4BFA-8C8E-44D53CFDA463 Q37098390-104BE5F4-CCFF-480D-8C3F-FE9EBFD49497 Q37136239-25D19577-7CC0-42F9-ACA3-580DE107417D Q37138907-E9AB83A4-73C1-4815-99DA-D580BD1A3345 Q37205880-5CC0905C-1F9C-49BB-9F34-6BD76608D86D Q37264576-68669F98-1D83-478B-8622-C800571E48A6 Q37316732-F45030D5-BB29-4D27-8DD6-2B3FBA25ECBC Q37381433-47EF7F7E-704F-4877-8BDF-FF3351AF23B4 Q37578291-BE4A4814-89BE-44D9-8C65-216BAAE3446C

P2860

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.

http://www.wikidata.org/entity/Q34405742

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Impact on life expectancy of H ...... nse to antiretroviral therapy.

@ast

Impact on life expectancy of H ...... nse to antiretroviral therapy.

@en

Impact on life expectancy of H ...... nse to antiretroviral therapy.

@nl

type

label

Impact on life expectancy of H ...... nse to antiretroviral therapy.

@ast

Impact on life expectancy of H ...... nse to antiretroviral therapy.

@en

Impact on life expectancy of H ...... nse to antiretroviral therapy.

@nl

prefLabel

Impact on life expectancy of H ...... nse to antiretroviral therapy.

@ast

Impact on life expectancy of H ...... nse to antiretroviral therapy.

@en

Impact on life expectancy of H ...... nse to antiretroviral therapy.

@nl

P1433

Q34405742-8F4A31A8-4090-4DC1-92F3-E327E4EA228D

P1476

Q34405742-8DEACC22-A262-47DA-B1A2-44A049DA4CB4

P2093

Q34405742-42D9534C-C216-46D8-99FF-2C9FD379AB7A

Q34405742-5C41042D-3FB1-434A-BB76-A56851CA75CB

Q34405742-6594E29D-4ADE-4C6E-8246-ED22DA2F23E6

Q34405742-6C1094FD-C1B4-44EB-B0CE-9FB25DCCFAFB

Q34405742-73BA96A0-7629-4F4B-9E6B-1B27502F7C39

Q34405742-7C9A64A9-093F-41AE-9E8B-4505FACB452B

Q34405742-9ABB16C1-C561-4E30-9B15-C157E5CCC14C

Q34405742-A48D43CD-B3A7-4EFA-92DD-0058880D2842

Q34405742-BE73DDD2-E180-4441-9C92-EAD28DE0E4C4

Q34405742-CBFB6F5C-CBD3-47A6-B46B-8805E7C630E6

P2860

Q34405742-05EC2CFD-F900-461E-AC69-16C632A90385

Q34405742-0C5DFA7F-5207-4076-AE12-9DC90A8343A4

Q34405742-12C1CC10-6D12-4698-810A-73E439818CC5

Q34405742-3907063F-F1AA-4628-8337-012DA0CBBFBE

Q34405742-4782F2A0-56A3-4040-A4EC-581E4A0CB03D

Q34405742-4AF03616-AF1E-4BE7-B553-D7157825AD06

Q34405742-5795FD4A-E710-49A3-9AF0-1C76686552A4

Q34405742-5CE91314-933E-4124-926E-C43C4F516860

Q34405742-5D7BFD77-ADC9-4F89-AEEA-9B7A077DCC88

Q34405742-5DC3C4AD-7099-4369-88F4-C06B74B5B53A

P304

Q34405742-1EC508AD-4811-4705-A5C3-CD6E32369607

P31

Q34405742-15527792-C6A6-4B6B-AB49-5E364A723947

P356

Q34405742-860FFF0F-B81B-474C-AAE5-1C77B9A05261

P407

Q34405742-D55ACA40-5BE8-47F8-A463-BFB40C3333A9

P433

Q34405742-FE7E6E9B-41F3-4511-92FC-0F4BAF0BBD2E

P478

Q34405742-F9D315D0-4E25-4B68-A56E-5263F887063D

P50

Q34405742-31E41148-AB92-4CE4-AA5F-22D0423EDB15

Q34405742-4F51111C-D4E8-4AFD-B0FC-5D6DA5CD8432

Q34405742-5A0847F8-3E77-44B4-A4DA-AA139BBAE4CB

Q34405742-97B27971-0F2C-4013-8562-926C80A6D75F

Q34405742-D7514642-9B61-4DA3-BABB-615F41D0E5E1

Q34405742-DC873C01-FCF6-4645-8B39-E903BB0A00EB

P577

Q34405742-75BE8EDA-9A3F-4DED-852B-8578D94F527E

P698

Q34405742-571D400C-893C-4637-9C34-766EFBA49849

P921

Q34405742-24DB0FE5-6C93-41BD-A86D-DD2FB47D630F

Q34405742-7664DA48-9EA9-44FB-A600-EE392612E8DC

Q34405742-83A23917-4DAB-4C34-9B33-AD15227472D9

P932

Q34405742-8D221C6E-ACB4-4DC5-BC1A-23720F5B4F70

P356

QAD.0000000000000243

P1433

P1476

Impact on life expectancy of H ...... onse to antiretroviral therapy

@en

P2093

Adrian Palfreeman

http://www.w3.org/2001/XMLSchema#string

Clifford Leen

http://www.w3.org/2001/XMLSchema#string

David Chadwick

http://www.w3.org/2001/XMLSchema#string

Frank Post

http://www.w3.org/2001/XMLSchema#string

John Walsh

http://www.w3.org/2001/XMLSchema#string

Jonathan Ainsworth

http://www.w3.org/2001/XMLSchema#string

Margaret Johnson

http://www.w3.org/2001/XMLSchema#string

Margaret T May

http://www.w3.org/2001/XMLSchema#string

Mark Gompels

http://www.w3.org/2001/XMLSchema#string

Mark Nelson

http://www.w3.org/2001/XMLSchema#string

P2860

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

Prevention of HIV-1 infection with early antiretroviral therapy

Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis

Inflammation, coagulation and cardiovascular disease in HIV-infected individuals

Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study

Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

Adherence to HIV combination therapy.

Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS

P304

1193-1202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000000243

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24556869

http://www.w3.org/2001/XMLSchema#string

P921

life expectancy

antiretroviral drug

P932

4004637

http://www.w3.org/2001/XMLSchema#string